A comparative study of two supraglottic airway devices for blind tracheal intubation

A Comparative study of Ambu Aura-i and Air-Q Supraglottic airway devices as conduit for blind tracheal intubation in patients with normal airway

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027981

Enrollment

176

Registered

2020-09-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ambu Aura-i: Blind tracheal intubation through Ambu Aura-i of size no. 3 and 4 Control Intervention1: Air-Q: Blind tracheal intubation through Air-Q intubating laryngeal airway of size

Eligibility

Inclusion criteria

Inclusion criteria: Weight 30 - 70 kgs ASA Physical status I/II Patients posted for elective surgeries under General Anaesthesia

Exclusion criteria

Exclusion criteria: Patients with predicted difficult airway ( mouth opening Patients with recent upper respiratory tract infection Patients with any oropharyngeal pathology Patient with any known pulmonary disease (like Asthma) and cardiovascular diseases (like hypertension). Obese patients with BMI >30 kg/m2 Patient with any conditions that increase the risk of gastro oesophageal regurgitation. H/O allergy to Latex or to any drugs used in protocol Patients not willing for participation

Design outcomes

Primary

Measure	Time frame
first attempt success rate of blind tracheal intubation through Ambu Aura-i and Air-Q supraglottic airway deviceTimepoint: At the end of study	—

Secondary

Measure	Time frame
ease of insertion of supraglottic airway device (SAD)Timepoint: At the time of insertion of Supraglottic airway device;ease of tracheal intubation through SADTimepoint: At the time of intubation through supraglottic airway device;no. of attempts of insertion of SADTimepoint: attempts at the time of SAD insertion;no.of attempts of tracheal intubation through SADTimepoint: attempts at the time of intubation;overall success rate of blind tracheal intubation through Ambu Aura-i and Air-QTimepoint: At the end of the study;time taken for insertion of SADTimepoint: in seconds, at the time of SAD insertion;time taken for tracheal intubation through SADTimepoint: in seconds, at the time of intubation	—

Measure

Time frame

ease of insertion of supraglottic airway device (SAD)Timepoint: At the time of insertion of Supraglottic airway device;ease of tracheal intubation through SADTimepoint: At the time of intubation through supraglottic airway device;no. of attempts of insertion of SADTimepoint: attempts at the time of SAD insertion;no.of attempts of tracheal intubation through SADTimepoint: attempts at the time of intubation;overall success rate of blind tracheal intubation through Ambu Aura-i and Air-QTimepoint: At the end of the study;time taken for insertion of SADTimepoint: in seconds, at the time of SAD insertion;time taken for tracheal intubation through SADTimepoint: in seconds, at the time of intubation

—

Countries

India

Contacts

Public ContactDr Afroza Syed

Government Medical College, Baroda

afroza7887@gmail.com9825359856

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026